Episode Details

Pfizer’s Midtown East HQ conversion hit a major snag with two buckled columns forcing a partial stop-work order, stalling a $720M project poised to deliver 1,600 luxury units. Developer Nathan Berman insists the delay is minor and the project was ahead of schedule, but with interest mounting on the massive loan and city approval pending, the financial pressure is intense. Known for transforming office towers into apartments, Berman faces his toughest test yet — especially as New York’s housing shortage could buoy demand. Meanwhile, lender Madison Realty stays silent, while all eyes watch for the green light to resume construction and salvage this record-breaking development.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/92ef9d0b5405219d